| 于建平 韩晓鹏 王璟 李三党 刘宏斌.应用siRNA干扰胃癌的研究进展[J].,2015,15(4):756-759 |
| 应用siRNA干扰胃癌的研究进展 |
| The Research Progress of siRNA Interfere Gastric Cancer |
| |
| DOI： |
| 中文关键词: 胃癌 RNAi siRNA 基因治疗 |
| 英文关键词: Gastric cancer RNAi siRNA Gene therapy |
| 基金项目:甘肃省科技厅科技重大专项资助项目（2010GS04390） |
|
| 摘要点击次数: 679 |
| 全文下载次数: 0 |
| 中文摘要: |
| 胃癌是消化系统最常见的恶性肿瘤，而我国是胃癌高发区，其发病率和死亡率均高于世界平均水平。在我国大多数患者明
确诊断时已进入进展期，所以大多数患者再行手术切除后还需放化疗治疗。近来随着对胃癌的研究深入，可通过对胃癌肿瘤标本
行分子检测给予患者药物靶向治疗，实现个体化治疗。RNA干涉（RNAi）技术被广泛用于基因功能的研究，并且在哺乳动物研究
中得到飞速发展. siRNA 是在RNAi 中起中心作用，其可抑制特定mRNA，以调节不同蛋白在肿瘤发生时的异常表达。对siRNA
的研究将为胃癌的基因治疗供更广阔的空间。 |
| 英文摘要: |
| Gastric cancer is the most common malignant neoplasm of digestive system. Our country is a high-risk area of gastric
cancer and its morbidity and mortality are higher than the world average. Most patients have entered the advanced stage when they were
diagnosed with gastric cancer. So most of them need to radiotherapy and chemotherapy after surgery. As the research moves along, gastric
cancer patients can get drug targeted therapy through the molecular detection of tumor specimens to realize the personalized treatment.
RNA interference (RNAi) technology is widely used for gene function study, and get the rapid development in the study of mammals.
siRNA plays a central role in RNAi, which possesses specific inhibits a mRNA, to adjust the different protein abnormal expressions
in tumors occur. The study of siRNA will provide a broader space for gastric cancer gene therapy. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
